Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. C.P. (Carolien) Schröder

Publicaties

cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer

Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer

Loonkloof in een UMC

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)

Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase 2b Trial

Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients

Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer

Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Lees meer

Pers/media

FES-PET-scan kan biopt vervangen bij uitgezaaide borstkanker

Scan kan biopt vervangen om hormoongevoeligheid bij uitgezaaide borstkanker te bepalen

Newly Approved PET Imaging Agent Solves Clinical Dilemmas in Breast Cancer Patients

Interview male breast cancer, Dutch Radio 1 programme ‘Met het oog op morgen'

Ook veel mannen lijden aan borstkanker

Inflammatory breast cancer, interview Run with Courage funding organization

Inflammatoir mammacarcinoom

Lees meer